Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Current Opinion in Chemical Biology|August 4, 2020
Domain-selective targeting of BET proteins in cancer and immunological diseasesMassimo Petretich, Emmanuel H Demont, Paola GrandiNature Genetics|May 27, 2014
Long-range enhancers regulating Myc expression are required for normal facial morphogenesisVeli Vural Uslu, Massimo Petretich, Sandra Ruf, et al.Scientific Reports|May 5, 2016
CPEB1 restrains proliferation of Glioblastoma cells through the regulation of p27(Kip1) mRNA translationSilvia Galardi, Massimo Petretich, Guillaume Pinna, et al.Journal of Medicinal Chemistry|July 22, 2020
GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) ProteinsRobert J Watson, Paul Bamborough, Heather Barnett, et al.Molecular Systems Biology|March 7, 2024
Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibitionMira L Burtscher, Stephan Gade, Martin Garrido-Rodriguez, et al.Journal of Medicinal Chemistry|December 30, 2025
BET Isoform Selectivity through Diverse Linkers for Bivalent Inhibitors: GSK785, a BRD2/4-Selective Bivalent BET InhibitorFrancesco Rianjongdee, Stephen J Atkinson, Paul Bamborough, et al.Nature|May 18, 2018
Author Correction: A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchiesCarsten Bahr, Lisa von Paleske, Veli V Uslu, et al.Nature|January 18, 2018
A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchiesCarsten Bahr, Lisa von Paleske, Veli V Uslu, et al.Cell|March 20, 2018
Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein HomeostasisMikhail M Savitski, Nico Zinn, Maria Faelth-Savitski, et al.Cancer Research Communications|July 19, 2024
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway ModulationAnna Rutkowska, H Christian Eberl, Thilo Werner, et al.Pageof 2